T2D accounts for about 90% of diabetes cases [4] and is a progressive metabolic pathology characterized by hyperglycemia distinguished by pancreatic β-cell malfunction and insulin resistance of peripheral tissues [5]. The gene discussed is INS; the disease is type 2 diabetes mellitus.